Results 271 to 280 of about 65,144 (350)

Associations between psychological inflexibility processes, pre‐sleep arousal and sleep quality

open access: yesPsychology and Psychotherapy: Theory, Research and Practice, EarlyView.
Abstract Objectives Psychological inflexibility, the model of psychopathology underlying Acceptance and Commitment Therapy (ACT), has been linked to a broad range of psychological problems, but its link with sleep quality is not well understood. This study aimed to identify relationships between psychological inflexibility processes (cognitive fusion ...
Lisa Mastin‐Purcell   +3 more
wiley   +1 more source

Cutaneous Mastocytosis in Pediatric Patients With Skin of Color: A Retrospective Cohort Study

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Cutaneous mastocytosis (CM) is a rare skin disease with limited data on its prevalence across different racial groups. This retrospective cohort study examines the characteristics of CM at Nationwide Children's Hospital (NCH) from January 2010 to June 2022, identifying 192 confirmed cases of CM and further stratifying this cohort to 155 ...
Trent D. Walker   +4 more
wiley   +1 more source

Neuroichthyosis With a De Novo Variant c.494C>T in ELOVL1 and Severe Pruritus Relieved by Dupilumab

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT We report a patient with neuroichthyosis with an ELOVL1 variant associated with severe pruritus who responded well to dupilumab therapy. Our case is the third known patient reported with this de novo heterozygous dominant variant. The feature of severe progressive pruritus greatly impairing quality of life is unique among these reports.
Danielle Marcoux   +4 more
wiley   +1 more source

Classical Juvenile Pityriasis Rubra Pilaris Treated With Secukinumab: Case Report and a Review of Biological Treatments in the Pediatric Population

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Pityriasis rubra pilaris (PRP) is a rare, chronic papulosquamous disorder with limited treatment options in pediatric patients. We report the case of a 9‐year‐old boy with juvenile PRP (type III), who achieved complete disease remission after treatment with secukinumab, an IL‐17A inhibitor, following initial therapeutic resistance to topical ...
Zeno Fratton   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy